Trust Stamp Advances Innovative R&D with IP and Personnel Growth
Trust Stamp (Nasdaq: IDAI, Euronext Growth: AIID ID) has appointed Prof. Reuben Farrugia as Malta Research Director, enhancing its R&D efforts in biometric identity solutions. Prof. Farrugia brings nearly two decades of expertise in biometrics and image processing. Trust Stamp plans to leverage his skills to innovate and patent new technologies for secure financial and societal inclusion. The company also announced collaboration with Malta Enterprise for a Medical QR Code solution and continues its strategic growth with an emphasis on privacy-first identity services.
- Appointment of Prof. Reuben Farrugia strengthens R&D capabilities.
- Continued investment in patent filings indicates commitment to innovation.
- Financial support from Malta Enterprise for Medical QR Code solution enhances product offerings.
- Expansion of biometric identity solutions aligns with market demand for privacy and security.
- None.
Sliema, Malta, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI, Euronext Growth: AIID ID), a global provider of AI-powered, privacy-first trust and identity services used across multiple sectors, welcomes Prof. Reuben Farrugia to its team as Malta Research Director amidst ongoing investment in research and development alongside multiple patent filings in early 2022.
As an internationally recognized authority in biometrics with nearly two decades of experience in image processing and computer vision and over 70 international peer-reviewed publications, Prof. Farrugia brings deep expertise to the Trust Stamp team. He maintains active industry leadership as an Associate Professor at the University of Malta, National Contact for the European Association of Biometrics (EAB), and IIEE Senior Member, having previously served as General Chair to the IEEE International Workshop on Biometrics and Forensics.
Trust Stamp Chief Technology Officer Scott Francis comments: “Trust Stamp has established a strong research-oriented science team with experts in artificial intelligence, cryptography, and biometrics, whose global backgrounds and diverse experience have driven innovation as the basis for the Company’s rapid success over the last six years. Reuben is a valuable addition to our team with exceptional insight and a highly developed skillset in the field of biometrics.
Continuing momentum from our record success in 2021 and Nasdaq listing in January of this year, Trust Stamp looks forward to working with Reuben to further develop, patent, and deliver new technologies that accelerate secure financial and societal inclusion while growing long-term recurring revenue.”
Trust Stamp’s continued push to innovate transformative privacy-first solutions follows multiple patents applications filed in the beginning of 2022, and recently announced financial support from Malta Enterprise for their next-generation Medical QR Code solution that layers data privacy, protection, and portability to complement current and future digital health certificate programs using the Company’s advanced tokenization technology to enable user-controlled access to medical data both on and offline.
Protected by Trust Stamp’s comprehensive presentation attack detection capabilities, the innovation works across identity modalities including the Company’s own expanding range of biometric capture and analysis tools for facial, palm, and fingerprint biometrics, which are optimized for accurate authentication without sharing any biometric data, using just a mobile phone.
When coupled with the Company's core privacy-first technology that cryptographically transforms identifying information and leverages the resulting Irreversibly Transformed Identity Token (IT2) for privacy-first identity-proofing, this development poses notable implications in addressing global, cross-market demand for privacy, security, and accessibility in digital medical records systems.
With continued growth in European operations, Trust Stamp recently announced the appointment of Josh Allen as CEO of the Company’s Malta and Rwanda-based subsidiaries, highlighting a strategic focus on agile expansion of their customer base through continued investment into a robust portfolio of transformative, privacy-first identity and trust solutions. Celebrating this ongoing progress, Malta Minister for Energy, Enterprise and Sustainable Development, Dr. Miriam Dalli visited Trust Stamp’s European R&D hub earlier this month.
Enquiries
Trust Stamp
Gareth Genner, Chief Executive Officer
Nisha Naik, Executive VP of Communications
Email: Shareholders@truststamp.ai
Davy (Euronext Growth Advisor)
Barry Murphy
Tel: +353 1 679 6363
Investor Relations
Crescendo Communications
Email: idai@crescendo-ir.com
Tel: +1 212-671-1021
About Trust Stamp
Trust Stamp is a global provider of AI-powered identity services for use in multiple sectors including banking and finance, regulatory compliance, government, real estate, communications, and humanitarian services. Its technology empowers organizations with advanced biometric identity solutions that reduce fraud, protect personal data privacy, increase operational efficiency, and reach a broader base of users worldwide through its unique data transformation and comparison capabilities.
Located in seven countries across North America, Europe, Asia, and Africa, Trust Stamp trades on the Nasdaq Capital Market (Nasdaq: IDAI) and Euronext Growth in Dublin (Euronext Growth: AIID ID). Founded in 2016 by Gareth Genner and Andrew Gowasack, the company now employs over 100 people.
Safe Harbor Statement: Caution Concerning Forward-Looking Remarks
All statements in this release that are not based on historical fact are “forward-looking statements” including within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The information in this announcement may contain forward-looking statements and information related to, among other things, the company, its business plan and strategy, and its industry. These statements reflect management’s current views with respect to future events-based information currently available and are subject to risks and uncertainties that could cause the company’s actual results to differ materially from those contained in the forward-looking statements. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made. The company does not undertake any obligation to revise or update these forward-looking statements to reflect events or circumstances after such date or to reflect the occurrence of unanticipated events.
